Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

MDS - 838

Updated Phase 2 Results of Elritercept in Patients With Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms

Preview of Updated Phase 2 Results of Elritercept in Patients With Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms

View Poster Contact Presenter

Poster Presenter

Authors

Part of Topic

Myelodysplastic Syndromes (MDS)

Updated Phase 2 Results of Elritercept in Patients With Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Other ePosters in

Topic

MDS - 098Artificial Intelligence in the Diagnosis of Severe Aplastic Anemia: A Sy...

MDS - 1007Rising Mortality and Persistent Disparities in Hematologic Malignancies...

MDS - 1034Cooperative Effects of U2AF1-S34 and BCOR Mutations in Myeloid Neoplasms

MDS - 1049Spliceosome-Targeting Therapies in SF3B1-Mutated Myelodysplastic Syndrom...

MDS - 1074A Phase 2 Open-Label Study to Assess the Tolerability of Ianalumab (VAY7...

ePosters in

Topics

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)